PfizerFlex Patient Support Program for IXIFI® – Plaque Psoriasis

About plaque psoriasis

Plaque psoriasis is the most common form of psoriasis, with up to 80 to 90% of people with psoriasis having this type. Usually it appears as raised, inflamed skin on the elbows, knees, torse or scalp, and can be painful or itchy. Often there are silvery scales covering swollen patches of skin.

What is IXIFI used for?

IXIFI is used in people with moderate to severe plaque psoriasis. Your doctor has chosen to treat your plaque psoriasis with IXIFI because your disease is still active even though you have tried other treatments.

How does IXIFI work?

Research has shown that in plaque psoriasis, the body overproduces a substance known as tumour necrosis factor alpha (TNF alpha). The active ingredient in IXIFI is called infliximab. Infliximab is a monoclonal antibody, a type of protein that recognizes and binds to other unique proteins. Infliximab binds to and neutralizes TNF alpha. Infliximab is made from mouse and human proteins.

IXIFI is a medicine that affects your immune system. IXIFI can lower the ability of your immune system to fight infections.

Usual dose

IXIFI will be given to you by a healthcare professional. The medicine will be given to you through a needle placed in a vein in your arm. This is called an infusion. The infusion will take about 2 hours.

During the infusion you will be monitored for side effects. You must stay for 1 to 2 hours after the infusion so that you can continue to be watched for any reactions to the medicine.

The recommended dose of IXIFI is 5 mg/kg.

Infusion 1

Infusion 2

Infusion 3

Every 8 weeks thereafter for all following infusion

If you do not show an adequate response at Week 14, after infusions at Weeks 0, 2, and 6, no additional treatment with IXIFI should be given.

Please refer to your patient leaflet for complete dosing instructions.

Welcome